Vitamin D for Cognition in Bipolar Disorder

NCT05357859 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2023-11-22

No results posted yet for this study

Summary

Conduct randomized double-blind controlled trial (RCT), to examine the effects of vitamin D on cognitive performance in euthymic BD.

Conditions

Interventions

DIETARY_SUPPLEMENT

solubilized vitamin D3

solubilized vitamin D3

DIETARY_SUPPLEMENT

medium chain triglyceride

MCT with same amount

Sponsors & Collaborators

  • Taipei City Hospital

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-03
Primary Completion
2023-11-17
Completion
2023-11-20

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05357859 on ClinicalTrials.gov